UNIGE document Scientific Article
previous document  unige:84326  next document
add to browser collection

The role of adipocytokines in atherogenesis and atheroprogression

Published in Current Drug Targets. 2015, vol. 16, no. 4, p. 295-320
Abstract Research investigations on adipose tissue were focused for several decades on its "storage" function. Emerging evidence unveiled adipose tissue as an endocrine organ releasing a several mediators termed as adipokines. Adipokine-mediated functions include both physiological and pathophysiological roles such as regulation of energy metabolism, immune response and vascular homeostasis, as well as inflammatory and metabolic diseases (i.e. atherogenesis, diabetes and obesity clustered in the concept of metabolic syndrome). A dysregulation of adipokine levels has been also suggested as a potential common mechanism underlying these disorders. For instance, an unbalance between pro- and anti-inflammatory adipokines was positively associated with traditional risk factors (dyslipidaemia, hypertension, insulin resistance) in obesity, diabetes and atherogenesis. Adipokine-mediated activities particularly affected endothelial dysfunction/activation and intraplaque inflammation/vulnerability. The purpose of this narrative review is to provide an overview on the role of adipokines in atherogenesis. Evidence from basic research studies about adipokine-induced regulation of vascular and immune cell subsets will be discussed. Finally, conflicting results from clinical trials we be reported, with an attempt to better understand the reason why promising basic research results did not allow a speedy "into human" translation for clinical management of atherogenesis.
PMID: 25382206
Full text
This document has no fulltext available yet, but you can contact its author by using the form below.
Research group L'athérosclérose et ses complications cliniques (591)
(ISO format)
CARBONE, Federico, MACH, François, MONTECUCCO, Fabrizio. The role of adipocytokines in atherogenesis and atheroprogression. In: Current Drug Targets, 2015, vol. 16, n° 4, p. 295-320. doi: 10.2174/1389450115666141109213439 https://archive-ouverte.unige.ch/unige:84326

277 hits

0 download


Deposited on : 2016-06-08

Export document
Format :
Citation style :